Elevated soluble Flt1 mediates an anti-angiogenic state in patients with ANCA-associated vasculitis
Sophie Roux(Université de Sherbrooke), Fádi Fakhouri(University Hospital of Lausanne), Régis Josien(Inserm), Étienne Larger(Inserm), Mélanie Néel(Inserm), Béatrice Charreau(Inserm), M. Hamidou(Centre Hospitalier Universitaire de Nantes), Noël Lamandé(Inserm), Marie Rimbert(Inserm), H. Terence Cook(Hammersmith Hospital), Alexandre Dufay(Institut de Transplantation Urologie en Nephrologie), Alan D. Salama(The Royal Free Hospital), Ruth J. Pepper(University College Hospital), Maryvonne Hourmant
Cited by 0
Related Papers
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
|Kidney International|2018|1k
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
|Annals of the Rheumatic Diseases|2013|454
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
A proposal for standardized grading of chronic changes in native kidney biopsy specimens
|Kidney International|2017|278
Genetic loci influencing kidney function and chronic kidney disease
|Nature Genetics|2010|269